Localization of striatal and nigral tachykinin receptors in the rat.
The effects of lesioning mesostriatal dopamine projections or striatal neurons on tachykinin binding in the basal ganglia were assessed in the rat. 6-Hydroxydopamine lesions of the medial forebrain bundle destroyed striatal dopamine terminals as assessed by [3H]mazindol autoradiography, but did not significantly affect the binding of NK-1 ([3H][Sar9,Met(O2)11]substance P) or NK-3 ([3H]senktide) tachykinin ligands in the striatum. 6-Hydroxydopamine lesions significantly reduced NK-3 binding in the substantia nigra pars compacta, but not the ventral tegmental area. In contrast, striatal quinolinic acid lesions reduced both NK-1 and NK-3 binding in the striatum, but failed to affect NK-3 binding in the substantia nigra. These findings suggest that both NK-1 and NK-3 receptors within the striatum are predominantly post-synaptic with respect to dopamine neurons, whereas nigral NK-3 receptors are located on dopaminergic neurons.
Stoessl
A J
AJ
Department of Clinical Neurological Sciences, University of Western Ontario, London, Canada.
D000818:Animals; D001345:Autoradiography; D003342:Corpus Striatum / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008454:Mazindol / Q000378:metabolism; D008474:Medial Forebrain Bundle / Q000187:drug effects; D016627:Oxidopamine / Q000494:pharmacology; D010446:Peptide Fragments / Q000378:metabolism; D017378:Quinolinic Acid / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D018039:Receptors, Tachykinin / Q000378:metabolism*; D013373:Substance P / Q000031:analogs & derivatives / Q000378:metabolism; D013378:Substantia Nigra / Q000378:metabolism*; D014018:Tissue Distribution
D010446:Peptide Fragments; D018039:Receptors, Tachykinin; C054724:senktide; D013373:Substance P; D016627:Oxidopamine; D008454:Mazindol; D017378:Quinolinic Acid